Scholarlink

Abstract <p>Modern concepts of the mechanisms of protein aggregation with an emphasis on immunoglobulin-like domains (Ig domains) as a structural platform predisposed to the formation of aggregates with amyloid properties are presented in this review. Particular attention is paid to the muscle proteins titin and myosin-binding protein C, which form not fibrillar, but amorphous amyloid aggregates with a cross-β structure without an increase in the total content of the secondary β-structure, capable of binding thioflavin T (ThT) and Congo red. The absence of a nucleation phase during the formation of amyloid aggregates of these proteins, as well as their partial disaggregation, allows us to declare a new, previously undescribed pathway of amyloid protein aggregation. We refer to it as self-templating amorphous β-assembly (conformational conversion by a prion-like mechanism), characteristic of multidomain proteins of the sarcomeric cytoskeleton.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immunoglobulin-Like Domains Are the Key to Understanding Amyloid Aggregation

  • 期刊论文

  • 发表日期：

    2026年4月6日

查看全文
  • L. G. Bobyleva,
  • I. M. Vikhlyantsev,
  • A. G. Bobylev

摘要

Abstract

Modern concepts of the mechanisms of protein aggregation with an emphasis on immunoglobulin-like domains (Ig domains) as a structural platform predisposed to the formation of aggregates with amyloid properties are presented in this review. Particular attention is paid to the muscle proteins titin and myosin-binding protein C, which form not fibrillar, but amorphous amyloid aggregates with a cross-β structure without an increase in the total content of the secondary β-structure, capable of binding thioflavin T (ThT) and Congo red. The absence of a nucleation phase during the formation of amyloid aggregates of these proteins, as well as their partial disaggregation, allows us to declare a new, previously undescribed pathway of amyloid protein aggregation. We refer to it as self-templating amorphous β-assembly (conformational conversion by a prion-like mechanism), characteristic of multidomain proteins of the sarcomeric cytoskeleton.